Inside Washington: Reshaping Biotech Drug Development

June 15, 2003
Jill Wechsler
Jill Wechsler

Jill Wechsler is BioPharm International's Washington Editor,

BioPharm International, BioPharm International-06-01-2003, Volume 16, Issue 6

by Jill Wechsler, BioPharm International FDA is examining policy options for incorporating genomic information into the regulatory process while encouraging manufacturers to share pharmacogenomic research.